<div>
  <ul>
    <li>
      <p>
        ClinOne, a provider of a clinical trial management platform, has raised a further USD 2 million, adding to its Series A round 
        <a href="https://sp-edge.com/updates/17676">
          held in April
        </a>
         and bringing the total funds raised by the company to around USD 10 million. The extension round was co-led by Boulder Ventures and Highpoint Ventures.
      </p>
    </li>
    <li>
      <p>
        The raised funds will be used to expand the company&rsquo;s operations and business reach.
      </p>
    </li>
    <li>
      <p>
        Post-funding, ClinOne also announced the appointment of Katherine Vandebelt and JeanMarie Markham to the company&rsquo;s board. The company noted that both are Life Science leaders, who will contribute their experience and strategic insights to support the company&rsquo;s planned growth.
      </p>
    </li>
    <li>
      <p>
        ClinOne noted that as of November 2023, its platform was being used across 60 countries by more than 80 sponsors, contract research organizations, and site networks. 
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prweb.com/releases/clinone-raises-additional-funding-from-boulder-ventures-and-highpoint-ventures-in-its-series-a-extension-names-top-life-science-leaders-to-its-board-of-directors-301974718.html">
      Press release
    </a>
  </p>
  <p>
    <a href="https://www.finsmes.com/2023/11/clinone-raises-2m-in-additional-series-a-funding.html">
      FinSMEs
    </a>
  </p>
  <p>
  </p>
</div>


Clinical Trial Technology

DISRUPTOR_PRESENT

<div>
 <ul>
  <li><p>ClinOne, a clinical trial management platform provider, has raised an additional $2 million in funding, following its Series A round held in April. This brings the company's total funds raised to approximately $10 million. Boulder Ventures and Highpoint Ventures co-led the extension round.</p></li>
  <li><p>The newly acquired funds will be used to expand ClinOne's operations and business reach.</p></li>
  <li><p>Following the funding, Katherine Vandebelt and JeanMarie Markham have been appointed to ClinOne's board. Both individuals are Life Science leaders and will contribute their experience and strategic insights to support the company's planned growth.</p></li>
  <li><p>As of November 2023, ClinOne's platform is currently utilized in 60 countries by over 80 sponsors, contract research organizations, and site networks.</p></li>
 </ul>
</div>

All Updates

ClinOne raises USD 2 million in Series A extension

ClinOne raises USD 3 million in Series A funding